Rajinder Suri is CEO-DCVMN responsible for leadership, governance, strategic orientation and operational excellence. Rajinder is member of COVAX Manufacturing & Supply Task Force Leadership Team, MI4A (Market Information for Access to Vaccines) Advisory Group to WHO on Malaria, Global TB Vaccines R&D Roadmap by EDCTP, Expert Group on Seasonal Influenza Vaccine and Market Design and Demand Intelligence pillar of the Partnerships for African Vaccine Manufacturing (PAVM). With 43 years of experience and deep insights of the industry including Pharmaceuticals and Biological products in India and International markets, has invested over 24 years at the top management level including four years on the Board of Directors of the Indian subsidiary of Sanofi Pasteur. Rajinder has been Member-Gavi-Policy & Planning Committee (PPC) as well as Vice-President, DCVMN Executive Committee (2014-16).